NDC 11695-4013-1 - DexaJect SP
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 11695-4013
- Requested NDC
- 11695-4013-1
- Package NDCs from labels
- 11695-4013-1
- Manufacturer
- Butler Animal Health Supply, LLC, D/B/A/ Henry Schein Animal Health | Bimeda, Inc. | Bimeda-MTC | Sanofi Chimie | Pharmacia and Upjohn Company LLC
- Effective date
- 2019-01-02
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Dexamethasone Sodium Phosphate 4mg Injection | Butler Animal Health Supply, LLC, D/B/A/ Henry Schein Animal Health | Bimeda, Inc. | Bimeda-MTC | Sanofi Chimie | Pharmacia and Upjohn Company LLC | 2019-01-02 | PRESCRIPTION ANIMAL DRUG LABEL |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| dexamethasone sodium phosphate | ACTIVE INGREDIENT | AI9376Y64P | DEXAJECT SP (DEXAMETHASONE SODIUM PHOSPHATE 4MG INJECTION) INJECTION [HENRY SCHEIN ANIMAL HEALTH, BUTLER ANIMAL HEALTH] | 6 | |
| dexamethasone | ACTIVE MOIETY | 7S5I7G3JQL | DEXAJECT SP (DEXAMETHASONE SODIUM PHOSPHATE 4MG INJECTION) INJECTION [HENRY SCHEIN ANIMAL HEALTH, BUTLER ANIMAL HEALTH] | 6 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Dexamethasone Sodium Phosphate | DEXAMETHASONE SODIUM PHOSPHATE | REMEDYREPACK INC. | 11f10a47-1c42-40e4-89d8-bb000fef497c | 2026-09-09 | Warnings, Adverse reactions | AI9376Y64P |
| Dexamethasone Sodium Phosphate | DEXAMETHASONE SODIUM PHOSPHATE | Sportpharm LLC | 9822a5c3-d3f1-4e0b-9963-32b22740e10e | 2026-08-31 | Warnings, Adverse reactions | AI9376Y64P |
| Dexamethasone sodium phosphate | DEXAMETHASONE SODIUM PHOSPHATE | Micro Labs Limited | c6f2563b-5a39-48bf-bcfe-71dd417bd970 | 2026-08-26 | Warnings, Adverse reactions | AI9376Y64P |
| Dexamethasone Sodium Phosphate | DEXAMETHASONE SODIUM PHOSPHATE | ASCLEMED USA INC. | a31b013f-924c-42f8-b8ab-ce60bb8ad7b8 | 2026-08-07 | Warnings, Adverse reactions | AI9376Y64P |
| Dexamethasone Sodium Phosphate | DEXAMETHASONE SODIUM PHOSPHATE | Sagent Pharmaceuticals | 4680d517-ed5a-4137-819c-122ee962a464 | 2026-08-06 | Warnings, Adverse reactions | AI9376Y64P |
| Dexamethasone Sodium Phosphate | DEXAMETHASONE SODIUM PHOSPHATE | Sportpharm LLC | a8aee11f-c928-41ef-8df8-e6d8b355536c | 2026-07-10 | Warnings, Adverse reactions | AI9376Y64P |
| Dexamethasone Sodium Phosphate | DEXAMETHASONE SODIUM PHOSPHATE | Fresenius Kabi USA, LLC | cca2c160-9188-48e8-9505-49a52388dcb7 | 2026-06-30 | Warnings, Adverse reactions | AI9376Y64P |
| Dexamethasone Sodium Phosphate | DEXAMETHASONE SODIUM PHOSPHATE | Fresenius Kabi USA, LLC | 7cbd9005-7df2-47ee-adb3-7244c1c69bc3 | 2026-06-30 | Warnings, Adverse reactions | AI9376Y64P |
| Dexamethasone Sodium Phosphate | DEXAMETHASONE SODIUM PHOSPHATE | Fresenius Kabi USA, LLC | 2b626a48-c7aa-4443-9164-a08ff069ccd1 | 2026-06-08 | Warnings, Adverse reactions | AI9376Y64P |
| Dexamethasone Sodium Phosphate | DEXAMETHASONE SODIUM PHOSPHATE | Cardinal Health 107, LLC | 6d3cbd54-93ef-40fe-b15a-7a4f52dc5f71 | 2026-05-29 | Warnings, Adverse reactions | AI9376Y64P |
| Dexamethasone Sodium Phosphate | DEXAMETHASONE SODIUM PHOSPHATE | Sportpharm LLC | 6c7ff5f7-5688-4fc4-9194-9e6b8e6fab59 | 2026-04-24 | Warnings, Adverse reactions | AI9376Y64P |
| Dexamethasone Sodium Phosphate | DEXAMETHASONE SODIUM PHOSPHATE | Cardinal Health 107, LLC | 7a7ee007-cd02-4f3f-8f0f-82c4964da6e6 | 2026-04-21 | Warnings, Adverse reactions | AI9376Y64P |
| Dexamethasone Sodium Phosphate | DEXAMETHASONE SODIUM PHOSPHATE | REMEDYREPACK INC. | 1596a3b4-8c2c-41b4-b1eb-af09863eaa13 | 2026-04-15 | Warnings, Adverse reactions | AI9376Y64P |
| DEXAMETHASONE SODIUM PHOSPHATE | DEXAMETHASONE SODIUM PHOSPHATE | HF Acquisition Co LLC, DBA HealthFirst | 946f3c1d-0362-d602-e053-2995a90a3d9a | 2026-03-23 | Warnings, Adverse reactions | AI9376Y64P |
| Dexamethasone Sodium Phosphate | DEXAMETHASONE SODIUM PHOSPHATE | Sportpharm LLC | 56bdd2f3-ae94-4fd9-9d05-5b53263a09c1 | 2026-03-20 | Warnings, Adverse reactions | AI9376Y64P |
| Dexamethasone Sodium Phosphate | DEXAMETHASONE SODIUM PHOSPHATE | REMEDYREPACK INC. | 6ea9e6ab-0d33-4635-9e98-aa2fbd8921cc | 2026-03-16 | Warnings, Adverse reactions | AI9376Y64P |
| DEXAMETHASONE SODIUM PHOSPHATE | DEXAMETHASONE SODIUM PHOSPHATE | A-S Medication Solutions | fe464a39-7820-435c-9385-a4a96d8a38c8 | 2026-02-24 | Warnings, Adverse reactions | AI9376Y64P |
| Dexamethasone Sodium Phosphate | DEXAMETHASONE SODIUM PHOSPHATE | A-S Medication Solutions | 0e4f0f22-e6a1-4725-addb-0cc91bed07e9 | 2026-02-02 | Warnings, Adverse reactions | AI9376Y64P |
| Dexamethasone Sodium Phosphate | DEXAMETHASONE SODIUM PHOSPHATE | Hikma Pharmaceuticals USA Inc. | 0277cc0a-2fd4-4605-a310-b613be84ee26 | 2026-01-22 | Warnings, Adverse reactions | AI9376Y64P |
| Dexamethasone Sodium Phosphate | DEXAMETHASONE SODIUM PHOSPHATE | Henry Schein, Inc. | c464ffde-f64e-4716-92d2-720a10793248 | 2026-01-02 | Warnings, Adverse reactions | AI9376Y64P |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.